This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Immunologic Deficiency Syndromes
and you are
between 18 and 36
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to test wether orally administered Beta-glucan has systemic effects in humans.

Provided treatments

  • : Beta-glucan (Glucan #300®)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01727895. The sponsor of the trial is Radboud University and it is looking for 15 volunteers for the current phase.
Official trial title:
Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans, a Pilot Study